Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities

Author:

Morgan Elizabeth A.1ORCID,Sweeney M. Patrick2,Tomoka Tamiwe3,Kopp Nadja4,Gusenleitner Daniel5,Redd Robert A.6,Carey Christopher D.17,Masamba Leo8,Kamiza Steve3,Pinkus Geraldine S.1,Neuberg Donna S.6ORCID,Rodig Scott J.1,Milner Danny A.1,Weinstock David M.49

Affiliation:

1. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;

2. Tulane University School of Medicine, New Orleans, LA;

3. Department of Histopathology, University of Malawi College of Medicine, Blantyre, Malawi;

4. Department of Medical Oncology,

5. Center for Immuno-Oncology, and

6. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;

7. Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle, United Kingdom;

8. Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi; and

9. Broad Institute of Harvard and MIT, Cambridge, MA

Abstract

Key Points NHL subclassification is lacking in Malawi due to resource constraints yet is critical for directing therapy. Targeted gene expression profiling facilitates objective assessment and segregation of biologically defined subsets of NHL from Malawi.

Publisher

American Society of Hematology

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3